Organization · Venture Capital

Integra Holdings Ltd.

Integra Holdings Ltd. is a Jerusalem-based healthcare investment company that focuses on early-stage life sciences innovations, particularly those emerging from the Hebrew University of Jerusalem. The firm provides strategic support to its portfolio companies from inception to commercialization.

Venture CapitalFunder

Overview

What Integra Holdings Ltd. does

What Integra Holdings Ltd. is

Integra Holdings Ltd. is a Jerusalem-based healthcare investment company that focuses on early-stage life sciences innovations, particularly those emerging from the Hebrew University of Jerusalem. The firm provides strategic support to its portfolio companies from inception to commercialization.

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Venture Capital
Founded
Founded in 2012
Approximate age
About 14 years
Structured capabilities
Funder
Last reviewed
May 5, 2026

Official channels

Find Integra Holdings Ltd. elsewhere

Open the official website or a supported primary organization account.

Capability profile

Integra Holdings Ltd. as a funder

Investment thesis

Integra Holdings aims to translate Hebrew University life-science excellence into commercial healthcare companies, focusing on innovations and intellectual property emerging from the university.

Focus narrative

Integra Holdings invests in early-stage research and technologies in the life sciences, employing a multidisciplinary team to identify promising innovations. The company provides support from inception to commercialization, ensuring that groundbreaking research translates into viable healthcare solutions.

Value beyond capital

Integra Holdings adds value to its portfolio companies by providing hands-on commercialization support from inception through company maturity, leveraging its exclusive access to Hebrew University innovations and a multidisciplinary team to ensure scientific merit and commercial feasibility.

Focus and fit

Stages
Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Series D · Growth Equity
Sectors
Biotech · Healthcare · AI · Diagnostics · Medical Devices
Regions
Global

Availability

Currently deploying
Yes

Portfolio and track record

Recorded portfolio count
11

Portfolio context

Ayana Pharma: A late-stage company developing a lipid-based cytotoxic agent for cancer treatment, currently under FDA review. Nectin Therapeutics: Focused on developing next-generation immune oncology therapies for cancer patients. Splisense: A preclinical company developing antisense oligonucleotides for cystic fibrosis and other genetic diseases. HighRAD: Provides an intelligent computer assessment support system for analyzing multi-organ imaging data. Neoprol: A preclinical company developing a unique formulation of Propofol to address bacterial contamination issues. Lipocure: Developing novel liposomal formulations for post-surgical pain management. OPhRx: Focused on developing topical formulations for ocular diseases. RNAble: Developing compounds that modulate RNA stability for treating specific cancers and genetic diseases. Lipomedix: A Phase Ib company developing a novel liposomal prodrug for cancer therapy.

Common questions

What to know about Integra Holdings Ltd.

Upseed classifies Integra Holdings Ltd. under the Venture Capital organization type. Its current public profile includes funder capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

May 5, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.